[Federal Register Volume 67, Number 161 (Tuesday, August 20, 2002)]
[Notices]
[Pages 53949-53950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-21080]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02223]


The Effect of Trichomonas vaginalis Infection on Vaginal Virus 
Loads Among HIV-Infected Women--Tulane University Health Sciences 
Center; Notice of Award of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
award of fiscal year (FY) 2002 funds for a grant program, ``The Effect 
of Trichomonas vaginalis Infection on Vaginal Virus Loads among HIV-
Infected Women'' to be performed by Tulane University Health Sciences 
Center, School of Public Health and Tropical Medicine.
    Detection and treatment of Trichomonas vaginalis (T. vaginalis) 
among HIV-infected women may be an important public health strategy in 
reducing the spread of HIV infection. This is of profound public health 
importance, as it would advance medical knowledge in the relationship 
between T. vaginalis (the most common non-viral STD among HIV-infected 
women) and vaginal shedding of the HIV virus.
    The study may lead to a determination of whether or not the 
effective treatment of T. vaginalis would result in a reduction in the 
spread of HIV. This study falls under the public health initiative 
Human Immunodeficiency Virus (HIV) Prevention.

B. Eligible Applicant

    Assistance is provided only to Tulane University Health Sciences 
Center, School of Public Health and Tropical Medicine. Tulane's 
application contained an important and unique scientific proposal that 
was not submitted in response to any existing program announcement, but 
does fall under the embrace of the Government's public health 
initiative Human Immunodeficiency Virus (HIV) Prevention. The research 
team at Tulane has a strong background in conducting similar studies. 
They are the largest provider of care to women co-infected with HIV and 
T. vaginalis in the gulf south region. They have the research, 
clinical, and laboratory expertise needed to conduct such a study. The 
CDC Division of Sexually Transmitted Disease Prevention (DSTD) 
performed a thorough review of Tulane's proposal and determined that it 
would significantly advance the state of medical knowledge, and provide 
a unique contribution to the understanding of T. vaginalis and HIV 
infectivity.

C. Funds

    Approximately $149,979 is being awarded in FY 2002. The award will 
begin on or about September 15, 2002, and will be made for a 24-month 
budget period within a project period of two years.

D. Where To Obtain Additional Information

    Business management technical assistance may be obtained from: 
William J. Ryan, Jr., Grants Management Officer, Procurement and Grants 
Office,

[[Page 53950]]

Centers for Disease Control and Prevention, 2920 Brandywine Road, Room 
3000, Atlanta, GA 30341-4146, Telephone number 770-488-2717, e-mail 
address: [email protected].
    For program technical assistance, contact: Emily Koumans, MD, 
Division of STD Prevention, Centers for Disease Control and Prevention, 
NCHSTP/DSTD, 10 Corporate Square Blvd, Atlanta, GA 30329, Telephone 
number 404-639-8870, e-mail address: [email protected].

    Dated: August 13, 2002.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 02-21080 Filed 8-19-02; 8:45 am]
BILLING CODE 4163-18-P